371
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

The novel tetrahydropyrimidine derivative as inhibitor of SARS CoV-2: synthesis, modeling and molecular docking analysis

, , &
Pages 10045-10056 | Received 22 Dec 2020, Accepted 30 May 2021, Published online: 26 Jun 2021

References

  • Babu, B., Chandrasekaran, J., Mohanbabu, B., Matsushita, Y., & Saravanakumar, M. (2016). Growth, physicochemical and quantum chemical investigations on 2-amino 5-chloropyridinium 4-carboxybutanoate – an organic crystal for biological and optoelectronic device applications. RSC Advances, 6(112), 110884–110897. https://doi.org/10.1039/C6RA15791B
  • Bahekar, S. S., & Shinde, D. B. (2004). Synthesis and anti-inflammatory activity of some [4,6-(4-substituted aryl)-2-thioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl]-acetic acid derivatives. Bioorganic and Medicinal Chemistry Letters, 14(7), 1733–1736. https://doi.org/10.1016/j.bmcl.2004.01.039
  • Becke, A. D. (1992). Density-functional thermochemistry. I. The effect of the exchange-only gradient correction. Journal of Chemical Physics, 96(3), 2155–2160. https://doi.org/10.1063/1.462066
  • Bruker. (2000). SHELXTL, version 6.14. Bruker AXS Inc.
  • Bruker. (2013). SAINT, version 8.34A. Bruker AXS Inc.
  • Bruker. (2014). SADABS, version 2014/4. Bruker AXS Inc.
  • Bruker. (2014). APEX2, version 2014.9-0. Bruker AXS Inc.
  • Chhillar, A. K., Arya, P., Mukherjee, C., Kumar, P., Yadav, Y., Sharma, A. K., Yadav, V., Gupta, J., Dabur, R., Jha, H. N., Watterson, A. C., Parmar, V. S., Prasad, A. K., & Sharma, G. L. (2006). Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: Novel compounds against aspergillosis. Bioorganic & Medicinal Chemistry, 14, 973–981. https://doi.org/10.1016/j.bmc.2005.09.014
  • Ciliberto, G., Mancini, R., & Paggi, M. G. (2020). Drug repurposing against COVID-19: Focus on anticancer agents. Journal of Experimental & Clinical Cancer Research, 39, 86. https://doi.org/10.1186/s13046-020-01590-2
  • Clare, B. W. (1994). Frontier orbital energies in quantitative structure–activity relationships: A comparison of quantum chemical methods. Theoretica Chimica Acta, 87(6), 415–430. https://doi.org/10.1007/BF01127805
  • Clare, B. W. (1995). Charge transfer complexes and frontier orbital energies in QSAR: A congeneric series of electron acceptors. Journal of Molecular Structure: Theochem, 337(2), 139–150. https://doi.org/10.1016/0166-1280(95)04135-S
  • Clare, B. W. (1995). The relationship of charge transfer complexes to frontier orbital energies in QSAR. Journal of Molecular Structure: Theochem, 331(1–2), 63–78. https://doi.org/10.1016/0166-1280(94)03783-H
  • Clark, D. E., & Pickett, S. D. (2000). Computational methods for the prediction of ‘drug-likeness’. Drug Discovery Today, 5(2), 549–558. https://doi.org/10.1016/S1359-6446(99)01451-8
  • Clercq, E. D. (2007). The design of drugs for HIV and HCV. Nature Reviews Drug Discovery, 6, 1001–1018. https://doi.org/10.1038/nrd2424
  • Cotten, M., Watson, S. J., Kellam, P., Al-Rabeeah, A. A., Makhdoom, H. Q., Assiri, A., Al-Tawfiq, J. A., Alhakeem, R. F., Madani, H., AlRabiah, F. A., Hajjar, S. A., Al-Nassir, W. N., Albarrak, A., Flemban, H., Balkhy, H. H., Alsubaie, S., Palser, A. L., Gall, A., Bashford-Rogers, R., … Memish, Z. A. (2013). Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: A descriptive genomic study. The Lancet, 382(9909), 1993–2002. https://doi.org/10.1016/S0140-6736(13)61887-5
  • COVID-19 (COVID-19) Wuhan, China. (2020). https://www.cdc.gov/coronavirus/novel-coronavirus-2019.html
  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
  • Daina A., & Zoete, A. (2016). Boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem, 11, 1117–1121. https://doi.org/10.1002/cmdc.201600182
  • Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology, 1263, 243–250. https://doi.org/10.1007/978-1-4939-2269-7_19
  • de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A. M., Galiano, M., Gorbalenya, A. E., Memish, Z. A., Perlman, S., Poon, L. L. M., Snijder, E. J., Stephens, G. M., Woo, P. C. Y., Zaki, A. M., Zambon, M., & Ziebuhr, J. (2013). Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. Journal of Virology, 87(14), 7790–7792. https://doi.org/10.1128/JVI.01244-13
  • Dunbar, P. G., Durant, G. J., Rho, T., Ojo, B., Huzl, J. J., Smith, D. A., El-Assadi, M. A., Sbeih, S., Ngur, D. 0., Periyasamy, S., Hoss, W., & Messer, W. S. (1994). Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists. Journal of Medicinal Chemistry, 37, 2774–2782. https://doi.org/10.1021/jm00043a016
  • Sharom, F. J. (2008). ABC, multidrug transporters: Structure, function and role in chemoresistance. Pharmacogenomics, 9, 105–127. https://doi.org/10.2217/14622416.9.1.105
  • Frisch M. J., Trucks G. W., Schlegel H. B., Scuseria G. E., Robb M. A., Cheeseman J. R., Scalmani, G., Barone, V., Petersson, G. A., Nakatsuji, H., Li, X., Caricato, M., Marenich, A., Bloino, J., Janesko, B. G., Gomperts, R., Mennucci, B., Hratchian, H. P., Ortiz, J. V. … Fox, D.J. (2009). Gaussian 09. Revision C.01, Gaussian, Inc.
  • Ganeshpurkar, A., Gutti, G., & Singh, S. K. (2019). RNA-Dependent RNA Polymerases and Their Emerging Roles in Antiviral Therapy. Viral Polymer, 1–42. https://doi.org/10.1016/B978-0-12-815422-9.00001-2
  • Guo, Y., Cao, Q., Hong, Z., Tan, Y., Chen, S., Jin, H., Tan, K., Wang, D., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research, 7, 11. https://doi.org/10.1186/s40779-020-00240-0
  • Guy, R. K., DiPaola, R. S., Romanelli, F., & Dutch, R. E. (2020). Rapid repurposing of drugs for COVID-19. Science, 368, 829–830. https://doi.org/10.1126/science.abb9332
  • Heaton, C., Miller, A., & Powell, R. (2001). Predicting the reactivity of fluorinated compounds with copper using semi-empirical calculations. Journal of Fluorine Chemistry, 107(1), 1–3. https://doi.org/10.1016/S0022-1139(00)00324-9
  • https://www.3dsbiovia.com/
  • Lamya Al-Wahaibi, H., Joubert, J., Olivier, B., Al-Shaalan, N. H., & El-Emam, A. A. (2019). Crystal structure, Hirshfeld surface analysis and DFT studies of 5-(adamantan-1-yl)-3-[(4-chlorobenzyl)sulfanyl]-4-methyl-4H-1,2,4-triazole, a potential 11β-HSD1 inhibitor. Scientific Reports, 9(1), 19745. https://doi.org/10.1038/s41598-019-56331-z
  • Lee, C., Yang, W., & Parr R. G. (1988). Development of the Colle–Salvetti correlation-energy formula into a functional of the electron density. Physical Review B, 37, 785–789. https://doi.org/10.1103/physrevb.37.785
  • Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0
  • Lu, H. (2019). Drug treatment options for the 2019-new coronavirus (2019-nCoV). BioScience Trends, 14(2020), 69–71. [10.5582/bst.2020.01020]
  • Macrae, C. F., Edgington, P. R., McCabe, P., Pidcock, E., Shields, G. P., Taylor, R., Towler, M., & van de Streek, J. (2006). Mercury: visualization and analysis of crystal structures. Journal of Applied Crystallography, 39(3), 453–457. https://doi.org/10.1107/S002188980600731X
  • Montanari, F., & Ecker, G. F. (2015). Prediction of drug-ABC-transporter interaction–Recent advances and future challenges. Advanced Drug Delivery Reviews, 86, 17–26. https://doi.org/10.1016/j.addr.2015.03.001
  • Nii-Trebi, N. I. (2017). Emerging and neglected infectious diseases: Insights, Advances, and Challenges. BioMed Research International, 2017, 5245021. https://doi.org/10.1155/2017/5245021
  • Organic Chemistry Portal. (2012). http://www.organic-chemistry.org/prog/peo/
  • Padmaja Ravikumar, L., Sajan, C., Hubert Joe, D. I., Jayakumar, V. S., Pettit, G., & Faurskov Nielsen, R. O. (2009). Density functional study on the structural conformations and intramolecular charge transfer from the vibrational spectra of the anticancer drug combretastatin-A2. Journal of Raman Spectroscopy, 40(4), 419–428. https://doi.org/10.1002/jrs.2145
  • Pawar, A. Y. (2020). Combating devastating COVID-19 by drug repurposing. International Journal of Antimicrobial Agents, 56(2), 105984. https://doi.org/10.1016/j.ijantimicag.2020.105984
  • Rajarajeswari, G. L., Anil Kumar, G. N., & Katrahalli, U. (2020). Crystal structure, quantum chemical and Hirshfeld surface analysis of N -ethyl-6-methyl-2-oxo-4-phenyl-1,2,3,4- tetrahydropyrimidine-5-carboxamide. Chemical Data Collections, 25, 100328. https://doi.org/10.1016/j.cdc.2019.100328
  • Ravikumar, C., Joe, I. H., & Jayakumar, V. S. (2008). Charge transfer interactions and nonlinear optical properties of push–pull chromophore benzaldehyde phenylhydrazone: A vibrational approach. Chemical Physics Letters, 460(4–6), 552–558. https://doi.org/10.1016/j.cplett.2008.06.047
  • Servi, S., Genc, M., Gür, S., & Koca, M. (2005). The synthesis and antimicrobial activity of some new methyl N-arylthiocarbamates, dimethyl N-aryldithiocarbonimidates and 2-arylamino-2-imidazolines. European Journal of Medicinal Chemistry, 40(7), 687–693. https://doi.org/10.1016/j.ejmech.2005.02.002
  • Shah, B., Modi, P., & Sagar, S. R. (2020). In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences., 252, 117652. https://doi.org/10.1016/j.lfs.2020.117652
  • Spackman, M. A., & Byrom, P. G. (1997). A novel definition of a molecule in a crystal. Chemical Physics Letters, 267(3–4), 215–220. https://doi.org/10.1016/S0009-2614(97)00100-0
  • Spackman, M. A., & Jayatilaka, D. (2009). Hirshfeld surface analysis. CrystEngComm, 11(1), 19–32. https://doi.org/10.1039/B818330A
  • Spek, A. L. (2009). Structure validation in chemical crystallography. Acta Crystallographica, 65, 148–155. https://doi.org/10.1107/S090744490804362X
  • Szakács, G., Váradi, A., Ozvegy-Laczka, C., & Sarkadi, B. (2008). The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discovery Today, 13, 379–393. https://doi.org/10.1016/j.drudis.2007.12.010
  • Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Gotte, M. (2019). Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by Remdesivir. Viruses, 11(4), 326. https://doi.org/10.3390/v11040326
  • Venkateshan, M., Muthu, M., Suresh, J., & Kumar, R. R. (2020). Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis, physicochemical, quantum chemical, modeling and molecular docking analysis. Journal of Molecular Structure, 1220, 128741. https://doi.org/10.1016/j.molstruc.2020.128741
  • Wolff, S. K., Grimwood, D. J., McKinnon, J. J., Turner, M. J., Jayatilaka, D., & Spackman, M. A. (2012). Crystal Explorer University of Western Australia. Version 3.1.
  • Xu, H.-T., Hassounah, S. A., Colby-Germinario, S. P., Oliveira, M., Fogarty, C., Quan, Y., Han, Y., Golubkov, O., Ibanescu, I., Brenner, B., Stranix, B. R., & Wainberg, M. A. (2017). Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitor. Journal of Antimicrobial Chemotherapy, 72, 727–734. [10.1093/jac/dkw514]
  • Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., Li, W., Liu, G., & Tang, Y. (2019). admetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics, 35, 1067–1069. https://doi.org/10.1093/bioinformatics/bty707
  • Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New England Journal of Medicine, 367, 1814–1820.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.